MIMEDX GROUP INC (MDXG) Stock Price, Forecast & Analysis
USA - NASDAQ:MDXG - US6024961012 - Common Stock
MDXG Key Statistics, Chart & Performance
The current stock price of MDXG is 6.72 USD. In the past month the price decreased by -0.3%. In the past year, price decreased by -26.96%.
MDXG Latest News, Press Relases and Analysis
MDXG Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 24.75 | 413.15B | ||
| AMGN | AMGEN INC | 15.73 | 185.19B | ||
| GILD | GILEAD SCIENCES INC | 15.53 | 157.81B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 25.09 | 111.66B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.12 | 76.88B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 906.47 | 60.60B | ||
| INSM | INSMED INC | N/A | 42.62B | ||
| NTRA | NATERA INC | N/A | 29.32B | ||
| BIIB | BIOGEN INC | 10.09 | 24.75B | ||
| UTHR | UNITED THERAPEUTICS CORP | 18.06 | 21.56B | ||
| INCY | INCYTE CORP | 16.18 | 20.29B | ||
| NBIX | NEUROCRINE BIOSCIENCES INC | 33.17 | 13.75B |
Related stock screener links
About MDXG
Company Profile
MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. The company is headquartered in Marietta, Georgia and currently employs 837 full-time employees. The company went IPO on 2007-08-20. Its product portfolio categories include Wound Care and Surgical. The Wound Care products include EPIFIX and EPIEFFECT, which are marketed for external use, such as in advanced wound care applications. Its EPICORD, EPICORD Expandable and EPIEFFECT product lines also offer an alternative treatment option to address larger, deeper wounds. Its Surgical and Other product offering includes AMNIOFIX and AMNIOEFFECT, which are used in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. The company also offers HELIOGEN, an advanced bovine collagen matrix containing type I and type III collagen that is intended for the management of moderately to heavily exudating wounds and to control minor bleeding.
Company Info
MIMEDX GROUP INC
1775 W Oak Commons Court, Ne
Marietta GEORGIA 30062 US
CEO: Timothy R. Wright
Employees: 837
Phone: 17706519100
MIMEDX GROUP INC / MDXG FAQ
Can you describe the business of MIMEDX GROUP INC?
MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. The company is headquartered in Marietta, Georgia and currently employs 837 full-time employees. The company went IPO on 2007-08-20. Its product portfolio categories include Wound Care and Surgical. The Wound Care products include EPIFIX and EPIEFFECT, which are marketed for external use, such as in advanced wound care applications. Its EPICORD, EPICORD Expandable and EPIEFFECT product lines also offer an alternative treatment option to address larger, deeper wounds. Its Surgical and Other product offering includes AMNIOFIX and AMNIOEFFECT, which are used in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. The company also offers HELIOGEN, an advanced bovine collagen matrix containing type I and type III collagen that is intended for the management of moderately to heavily exudating wounds and to control minor bleeding.
What is the stock price of MIMEDX GROUP INC today?
The current stock price of MDXG is 6.72 USD. The price decreased by -5.35% in the last trading session.
Does MDXG stock pay dividends?
MDXG does not pay a dividend.
What is the ChartMill rating of MIMEDX GROUP INC stock?
MDXG has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
What is the Price/Earnings (PE) ratio of MIMEDX GROUP INC (MDXG)?
The PE ratio for MIMEDX GROUP INC (MDXG) is 18.67. This is based on the reported non-GAAP earnings per share of 0.36 and the current share price of 6.72 USD.
Can you provide the market cap for MIMEDX GROUP INC?
MIMEDX GROUP INC (MDXG) has a market capitalization of 994.29M USD. This makes MDXG a Small Cap stock.
Who owns MIMEDX GROUP INC?
You can find the ownership structure of MIMEDX GROUP INC (MDXG) on the Ownership tab.
MDXG Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to MDXG. When comparing the yearly performance of all stocks, MDXG is a bad performer in the overall market: 80.53% of all stocks are doing better.
MDXG Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to MDXG. MDXG has an excellent financial health rating, but there are some minor concerns on its profitability.
MDXG Financial Highlights
Over the last trailing twelve months MDXG reported a non-GAAP Earnings per Share(EPS) of 0.36. The EPS decreased by -35.71% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 10.38% | ||
| ROA | 12.8% | ||
| ROE | 17.09% | ||
| Debt/Equity | 0.07 |
MDXG Forecast & Estimates
11 analysts have analysed MDXG and the average price target is 12.44 USD. This implies a price increase of 85.18% is expected in the next year compared to the current price of 6.72.
For the next year, analysts expect an EPS growth of 49.48% and a revenue growth 17.88% for MDXG